Mesothelioma Cancer Centers
Hematology and Oncology Associates of Central New York was founded in 1982. Since then, it has grown into a 65,000 square feet cancer center and is staffed by 10 physicians, 22 nurse practitioners/physician assistants and over 200 allied health care workers.
The facility has grown to include four separate sites around the Central New York area; East Syracuse, Onondaga Hill, Auburn and Camillus. Services offered at the HOA sites include traditional cancer therapies, like chemotherapy and radiation, ambulatory infusion and an in house laboratory. Patients may also access complimentary therapies such as Reiki, acupuncture and massage therapy.
HOA cancer patients have access to clinical research trials and a staff that collaborates with major cancer centers across the nation through its affiliation with the National Cancer Institute. Currently, HOA patients have the opportunity to participate in over 115 clinical cancer research trials that address issues of cancer control as well as prevention trials that provide treatment with investigational therapies for cancer in various stages. Prevention trials also focus on the prevention of cancer-related side effects in addition to quality of life improvements and basic disease prevention.
The centerpiece of the HOA Cancer Center is the Varian Clinac iX, one the most advanced model of linear accelerator available today. This linear accelerator is used in the delivery of radiation treatments using a technology known as Image Guided Radiation Therapy (IGRT).
In addition, nurses at the Ambulatory Infusion center provide chemotherapy to patients in a comfortable and non-institutional like environment.
- Biological and immunotherapy
- Clinical trials
- CyberKnife robotic surgery
- Genetic risk screening
- Hormone therapy
- Medical oncology
- Palliative care services
- Radiation oncology
- ACHC Specialty Pharmacy with Oncology Distinction Accreditation
- QOPI Certified Cancer Center
- CEO Cancer Gold Standard-accredited employer
- Oncology Medical Home Certified
- Commission on Cancer Member
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette